Laboratoires Pierre Fabre

Pierre Fabre Mdicament is Granted Authorisation in Australia to Market the Milnacipran JONCIA to Treat Fibromyalgia

Sales of Dermo-Cosmetics on the Internet: Ruling by the EU Court of Justice Allows Pierre Fabre Laboratories to Defend Their Right to an Individual Exemption

Internet Sales of Dermocosmetics: the Paris Court of Appeal Refers the Case to the Court of Justice of the European Communities

CASTRES, France, November 21, 2011 - The Therapeutic Goods Administration (TGA), Australia's regulatory body for therapeutic products, granted Pierre Fabre Mdicament's milnacipran market authorisation for the treatment of fibromyalgia ("for the management of fibromyalgia").

MORE..

CASTRES, France, October 13, 2011 - Pierre Fabre Laboratorieshave beenopposed to the sale of dermo-cosmetic products on the Internet for many years.

MORE..

Older News

CASTRES, France - The case opposing the French Competition Authority and Pierre Fabre Dermocosmetics (PFDC) came before the Paris Court of Appeal on Thursday, 29 October 2009.

MORE..